Table 3 Baseline comorbidities categorized by ESA dose
Comorbidity - N (%) | ESA dose (>18000 IU/week) N = 7 | ESA dose (≤18000 IU/week) N = 60 | P |
|---|---|---|---|
Diabetes | 3 (42.9) | 26 (43.3) | 0.99 |
Ischemic Heart Disease | 1 (14.4) | 20 (33.3) | 0.41 |
Heart failure | 1 (14.3) | 11 (18.3) | 0.99 |
Peripheral vascular disease | 3 (42.9) | 12 (20) | 0.18 |
Stroke | 0 (0) | 7 (11.7) | 0.99 |
Chronic Obstructive | |||
Pulmonary Disease (COPD) | 1 (14.3) | 16 (26.7) | 0.67 |
Arrhytmias | 2 (28.6) | 11 (18.3) | 0.61 |
Tumoral History | 2 (28.6) | 7 (11.7) | 0.24 |
Hepatopathy | 1 (14.3) | 3 (5) | 0.36 |
Hypertension | 7 (100) | 58 (96.7) | 0.99 |